Loading...

Aaron Rosenberg

Title(s)Assistant Professor, Hematology and Oncology
SchoolUniversity of California, Davis
AddressCancer Center
CA 95817
Emailasrosenberg@ucdavis.edu
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma. J Natl Cancer Inst. 2019 01 01; 111(1):78-85. Rosenberg AS, Brunson A, Jonas BA, Keegan THM, Wun T. PMID: 29897481.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2018 May; 45(4):536-542. Pon TK, Mahajan A, Rosenberg A, Amin A, Shah D, Jenkins I, Gupta V, Hofmann H, Bejjani A, White R. PMID: 29574610.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California. Cancer. 2018 05 01; 124(9):1938-1945. Ho G, Wun T, Muffly L, Li Q, Brunson A, Rosenberg AS, Jonas BA, Keegan THM. PMID: 29451695.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2018 03; 18(3):210-218. Gupta S, Abouzaid S, Liebert R, Parikh K, Ung B, Rosenberg AS. PMID: 29429817.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. Impact of latency time on survival for adolescents and young adults with a second primary malignancy. Cancer. 2018 03 15; 124(6):1260-1268. Goldfarb M, Rosenberg AS, Li Q, Keegan THM. PMID: 29205296.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors. JAMA Oncol. 2017 Nov 01; 3(11):1554-1557. Keegan THM, Bleyer A, Rosenberg AS, Li Q, Goldfarb M. PMID: 28426850.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    7. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J. 2017 09 08; 7(9):e605. Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM, Jonas BA. PMID: 28885611.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. Br J Haematol. 2017 07; 178(1):72-80. Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM. PMID: 28542862.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Br J Haematol. 2017 07; 178(2):319-326. Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T. PMID: 28369826.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    10. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders. Clin Lymphoma Myeloma Leuk. 2016 12; 16(12):684-692.e3. Rosenberg AS, Ruthazer R, Paulus JK, Kent DM, Evens AM, Klein AK. PMID: 27771291.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay. Clin Biochem. 2016 Oct; 49(15):1202-1204. Rosenberg AS, Bainbridge S, Pahwa R, Jialal I. PMID: 27475249.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival. Am J Hematol. 2016 06; 91(6):560-5. Rosenberg AS, Klein AK, Ruthazer R, Evens AM. PMID: 26928381.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Breast cancer and thrombosis: timing matters. Blood. 2016 Feb 18; 127(7):793-4. Paulus JK, Rosenberg AS. PMID: 26893393.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging. ScientificWorldJournal. 2014; 2014:380814. Shah GL, Rosenberg AS, Jarboe J, Klein A, Cossor F. PMID: 25374938.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor. Expert Opin Investig Drugs. 2013 Jun; 22(6):787-94. Rosenberg A, Mathew P. PMID: 23540855.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells